Product Screening
Honest, structured qualification of your AI medical product (clinical need, regulatory feasibility, commercial defensibility) before you commit the next 18 months.
Overview
Most AI medical startup failures are visible by month six. The clinical need was overstated, the regulatory path was misread, or the commercial defensibility evaporated against a generic alternative. The founders did not lack effort. They lacked an early honest assessment.
We run that assessment. Three lenses, applied with discipline, with a written conclusion you can take to your board or your next investor conversation.
Our Process
-
1
Clinical need stress-test
Interviews with practicing specialists outside your existing advisory pool.
-
2
Regulatory feasibility scan
Likely classification, predicate landscape, evidence requirements, realistic timeline.
-
3
Commercial defensibility
Adjacent solutions, reimbursement reality, switching cost, network effects.
-
4
Synthesis & verdict
Honest written verdict with documented dissent.
-
5
Next-step plan
If go, what to invest in first; if pivot, what direction looks viable.
Frequently Asked Questions
Is this the same as a market research report?
No. Market research describes a market. We test whether your product fits.
How candid is the verdict?
Candid enough to be useful. We do not soft-pedal.
Can investors see the report?
Yes, we recommend it. Investors value independence.
How long is the engagement?
Typically 4-6 weeks.
Get the honest read before you raise.
Send us your product and current evidence. We will return a screening verdict within six weeks.
Start a Conversation